Psychiatric Journals

Psychiatry

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mease PJ - On January 14, 2009 the Food and Drug Administration approved the use of SavellaTM (milnacipran) for the treatment of fibromyalgia. This third approved drug offers health care providers yet another treatment option for their fibromyaliga patients. Dr. Philip Mease’s detailed article covers the scientific specifics of Savella’s efficacy in a fibromyalgia treatment regimen and offers the promise of a better quality of life for people living with this chronic pain condition.


Today in Neuro/Psych Pharmacol...keeping you current

Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09

Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09

Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder
International Clinical Psychopharmacology, 10/23/09

Today in Other Psychiatry...keeping you current

Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09

Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09

Management of agitation and aggression associated with Alzheimers disease: controversies and possible solutions
Current Opinion in Psychiatry, 10/12/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address